• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    B. Riley reiterated coverage on SRAX with a new price target

    2/12/21 8:22:29 AM ET
    $SRAX
    Advertising
    Consumer Discretionary
    Get the next $SRAX alert in real time by email
    B. Riley reiterated coverage of SRAX with a rating of Buy and set a new price target of $7.50 from $4.50 previously
    Get the next $SRAX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SRAX

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $SRAX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Dawson James initiated coverage on SRAX with a new price target

      Dawson James initiated coverage of SRAX with a rating of Buy and set a new price target of $10.00

      4/19/21 9:31:00 AM ET
      $SRAX
      Advertising
      Consumer Discretionary
    • B. Riley reiterated coverage on SRAX with a new price target

      B. Riley reiterated coverage of SRAX with a rating of Buy and set a new price target of $7.50 from $4.50 previously

      2/12/21 8:22:29 AM ET
      $SRAX
      Advertising
      Consumer Discretionary
    • Ladenburg Thalmann initiated coverage on SRAX with a new price target

      Ladenburg Thalmann initiated coverage of SRAX with a rating of Buy and set a new price target of $7.00

      2/8/21 7:58:16 AM ET
      $SRAX
      Advertising
      Consumer Discretionary

    $SRAX
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • SRAX Signs Agreement to Merge with DNA Holdings

      Westlake Village, CA, May 08, 2024 (GLOBE NEWSWIRE) -- SRAX Inc. (OTC:SRAX), a financial technology company that unlocks data and insights for publicly traded companies through its SaaS platform Sequire, announced today it has entered into a definitive merger agreement with DNA Holdings Venture Inc. pursuant to which the shareholders of DNA will become the majority owners of SRAX's outstanding common stock as more fully described below upon the closing of the merger. DNA has been a long term investor in SRAX and currently owns approximately 35% of the company.  DNA is  a Web3 investment company which provides both advisory services and invests in Web3 infrastructure. The company was foun

      5/8/24 8:00:00 AM ET
      $SRAX
      Advertising
      Consumer Discretionary
    • SRAX SELECTS XDEFI AS WEB3 WALLET PARTNER, ENABLING SECURE ACCESS TO DIGITAL ASSETS FOR ACTIVE EQUITY INVESTORS

      Los Angeles, March 05, 2024 (GLOBE NEWSWIRE) -- Los Angeles, [5 March 2024] - SRAX Inc. (OTC:SRAX), a financial technology company that unlocks data and insights for publicly traded companies through its SaaS platform Sequire, today announced it has selected XDEFI as its Web3 wallet partner. XDEFI is a pioneering multichain cryptocurrency wallet. The partnership will enable SRAX's network of active equity investors to access decentralized applications and assets spanning 200+ blockchains, seamlessly and securely. In addition, SRAX clients who download the wallet will be eligible for airdrops in $XDEFI tokens and many future token airdrops.  In 2023, over $5 billion was given away through

      3/5/24 8:30:00 AM ET
      $SRAX
      Advertising
      Consumer Discretionary
    • SRAX SHAREHOLDER LETTER

      Westlake Village, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Dear Shareholders, As I write to you today, I do so with a sense of deep reflection on the year that has passed. It's been a period that tested our resilience. I want to express my sincere regret for the concerns and frustrations you may have experienced as a result of our stock price. Addressing Our Challenges Head-On Our delisting from the NASDAQ market was a moment for serious introspection. Looking back, there were areas where we should have been more proactive, especially as it relates to our accounting team's leadership and the complexities of the accounting for our business.  Bringing in new experts was a turning point for th

      12/18/23 7:00:00 AM ET
      $SRAX
      Advertising
      Consumer Discretionary